Insiders · AMRX

AMRX insider transactions

Amneal Pharmaceuticals Inc. (AMRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

AMRX insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Amneal Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.

• J Kevin BuchiDirector
• Andrew S BoyerExecutive Vice President-$4.65M
• John KielyDirector-$1.7M
• Jason B. DalyEVP, Chief Legal Officer, since January 2022-$5.25M
• Nikita ShahExecutive Vice President-$7.82M
• Tushar Bhikhubhai Patel10% owner-$41.8M
• Chintu PatelCo-CEO, Director+$626K
• Gautam PatelDirector+$211K-$3.95M
• Chirag K. PatelPresident & Co-CEO, Director+$626K
• Deborah M. AutorDirector, since July 2022-$1.04M
• Jeffrey P. GeorgeDirector
• Ted C NarkDirector-$586K
• Paul M MeisterDirector
• Shlomo YanaiDirector
• Tasos KonidarisExecutive Vice President & CFO-$5.55M
• Emily Peterson AlvaDirector-$712K
• Dipan PatelInsider
• Tpg Gp A, LLCInsider, since January 2022-$9.1M
• Gustavo PesquinOfficer, since September 2022
• Joseph TodiscoOfficer-$254K
• Stephen ManzanoOfficer

Recent Form 3, 4, and 5 filings for AMRX

• 48d
  Director Buchi J Kevin gifted 20,445 shares (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 55d
  Director Buchi J Kevin exercised 20,445 shares at a strike of $14.45, increasing direct ownership by 27% to 95,522 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 67d
  Executive Vice President Boyer Andrew S gifted 80,000 shares, decreasing direct ownership by 29% to 193,646 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 75d
  Executive Vice President Boyer Andrew S gifted 152,426 shares, decreasing direct ownership by 36% to 273,646 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 86d
  Director Kiely John sold $882,000 worth of shares (50,000 units at $17.64) and gifted 10,000 shares, decreasing direct ownership by 23% to 200,252 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 87d
  Executive Vice President Shah Nikita sold $2,563,517 worth of shares (146,403 units at $17.51), decreasing direct ownership by 37% to 253,390 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 87d
  EVP, Chief Legal Officer Daly Jason B. sold $3,771,050 worth of shares (216,613 units at $17.41), decreasing direct ownership by 86% to 35,171 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 87d
  SEC Form 4 filed by Director Buchi J Kevin

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 88d
  Large owner Patel Tushar Bhikhubhai was granted 12,763,469 shares (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 88d
  Co-CEO Patel Chintu was granted 6,381,734 shares (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 88d
  Director Patel Gautam was granted 283,632 shares (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 88d
  President & Co-CEO Patel Chirag K. was granted 6,381,734 shares (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 180d
  Director Autor Deborah M. sold $450,558 worth of shares (34,819 units at $12.94), decreasing direct ownership by 27% to 93,660 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 184d
  Director Buchi J Kevin converted options into 34,819 shares, increasing direct ownership by 86% to 75,077 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 184d
  Director Autor Deborah M. converted options into 34,819 shares, increasing direct ownership by 37% to 128,479 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 184d
  Director George Jeffrey P. converted options into 34,819 shares, increasing direct ownership by 11% to 344,614 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 184d
  Director Patel Gautam converted options into 34,819 shares, increasing direct ownership by 2% to 1,643,963 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 184d
  Director Kiely John converted options into 34,819 shares, increasing direct ownership by 15% to 260,252 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 184d
  Director Nark Ted C converted options into 34,819 shares, increasing direct ownership by 12% to 325,848 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 184d
  Director Meister Paul M converted options into 48,747 shares, increasing direct ownership by 6% to 832,800 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 184d
  Director Yanai Shlomo converted options into 34,819 shares, increasing direct ownership by 12% to 320,804 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 226d
  Amendment: SEC Form 4 filed by Patel Chintu

  4/A - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 226d
  Amendment: SEC Form 4 filed by Patel Chirag K.

  4/A - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 248d
  Co-CEO Patel Chintu converted options into 886,468 shares and covered exercise/tax liability with 361,980 shares, increasing direct ownership by 61% to 1,388,521 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 248d
  President & Co-CEO Patel Chirag K. covered exercise/tax liability with 350,978 shares and converted options into 886,468 shares, increasing direct ownership by 62% to 1,393,470 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 248d
  EVP, Chief Legal Officer Daly Jason B. converted options into 426,819 shares and covered exercise/tax liability with 185,641 shares, increasing direct ownership by 2,274% to 251,784 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 248d
  Executive Vice President & CFO Konidaris Tasos converted options into 633,865 shares and covered exercise/tax liability with 306,583 shares, increasing direct ownership by 268% to 449,434 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 248d
  Executive Vice President Boyer Andrew S converted options into 548,953 shares and covered exercise/tax liability with 275,307 shares, increasing direct ownership by 180% to 426,072 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 248d
  Executive Vice President Shah Nikita converted options into 508,499 shares and covered exercise/tax liability with 255,109 shares, increasing direct ownership by 173% to 399,793 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 250d
  SEC Form 4 filed by Executive Vice President Shah Nikita

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 250d
  SEC Form 4 filed by EVP, Chief Legal Officer Daly Jason B.

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 250d
  SEC Form 4 filed by Co-CEO Patel Chintu

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 250d
  SEC Form 4 filed by Executive Vice President & CFO Konidaris Tasos

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 250d
  SEC Form 4 filed by President & Co-CEO Patel Chirag K.

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 250d
  SEC Form 4 filed by Executive Vice President Boyer Andrew S

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 354d
  Director Nark Ted C sold $586,000 worth of shares (50,000 units at $11.72), decreasing direct ownership by 15% to 291,029 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 359d
  Executive Vice President Shah Nikita exercised 131,856 shares at a strike of $2.75 and sold $1,571,724 worth of shares (131,856 units at $11.92) (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 437d
  Director Kiely John sold $295,360 worth of shares (32,000 units at $9.23), decreasing direct ownership by 12% to 225,433 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 440d
  Executive Vice President Shah Nikita sold $1,166,223 worth of shares (120,832 units at $9.65), decreasing direct ownership by 45% to 146,403 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 443d
  Executive Vice President Boyer Andrew S exercised 175,000 shares at a strike of $2.75 and sold $2,619,309 worth of shares (279,244 units at $9.38), decreasing direct ownership by 41% to 152,426 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 450d
  Executive Vice President Shah Nikita sold $666,037 worth of shares (71,694 units at $9.29), decreasing direct ownership by 21% to 267,235 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 450d
  Executive Vice President & CFO Konidaris Tasos sold $4,663,070 worth of shares (499,730 units at $9.33), decreasing direct ownership by 80% to 122,152 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 452d
  Executive Vice President Shah Nikita sold $452,000 worth of shares (50,000 units at $9.04), decreasing direct ownership by 13% to 338,929 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 452d
  EVP, Chief Legal Officer Daly Jason B. sold $199,100 worth of shares (22,000 units at $9.05), decreasing direct ownership by 67% to 10,606 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 452d
  Executive Vice President Boyer Andrew S sold $302,596 worth of shares (33,436 units at $9.05), decreasing direct ownership by 12% to 256,670 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 508d
  Director Patel Gautam sold $761,146 worth of shares (94,906 units at $8.02), decreasing direct ownership by 6% to 1,609,144 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 514d
  Director Patel Gautam sold $452,537 worth of shares (56,426 units at $8.02), decreasing direct ownership by 3% to 1,704,050 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 538d
  Executive Vice President Shah Nikita sold $372,481 worth of shares (49,140 units at $7.58), decreasing direct ownership by 11% to 388,929 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 544d
  Director Kiely John sold $379,500 worth of shares (50,000 units at $7.59), decreasing direct ownership by 16% to 257,433 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 549d
  Director Buchi J Kevin converted options into 40,258 shares (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 549d
  Director Yanai Shlomo converted options into 40,258 shares, increasing direct ownership by 16% to 285,985 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 549d
  Director Autor Deborah M. converted options into 40,258 shares, increasing direct ownership by 75% to 93,660 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 549d
  Director Nark Ted C converted options into 40,258 shares, increasing direct ownership by 13% to 341,029 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 549d
  Director Kiely John converted options into 40,258 shares, increasing direct ownership by 15% to 307,433 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 549d
  Director George Jeffrey P. converted options into 40,258 shares, increasing direct ownership by 15% to 309,795 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 549d
  Director Alva Emily Peterson converted options into 40,258 shares, increasing direct ownership by 24% to 211,029 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 549d
  Director Meister Paul M converted options into 56,361 shares, increasing direct ownership by 8% to 784,053 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 549d
  Director Patel Gautam converted options into 40,258 shares, increasing direct ownership by 2% to 1,760,476 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 551d
  Director Patel Gautam sold $69,344 worth of shares (8,668 units at $8.00), decreasing direct ownership by 0.50% to 1,720,218 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
• 585d
  Director Patel Gautam sold $664,000 worth of shares (80,000 units at $8.30), decreasing direct ownership by 4% to 1,728,886 units (SEC Form 4)

  4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)